首页|血清游离前列腺特异性抗原、CXC趋化因子配体4L1水平与前列腺癌根治术患者临床特征及预后的关系

血清游离前列腺特异性抗原、CXC趋化因子配体4L1水平与前列腺癌根治术患者临床特征及预后的关系

扫码查看
目的 探讨血清游离前列腺特异性抗原(fPSA)、CXC趋化因子配体4L1(CXCL4L1)水平与前列腺癌根治术患者临床特征及预后的关系.方法 收集80例前列腺癌根治术患者的病历资料,比较不同临床特征前列腺癌根治术患者的血清fPSA、CXCL4L1水平.随访并记录患者的预后情况,比较不同预后前列腺癌根治术患者的血清fPSA、CXCL4L1水平.前列腺癌根治术临床特征和预后的影响因素采用多因素Logistic回归分析.相关性分析采用Pearson相关分析.结果 T分期为T3~4期、有淋巴结转移、分化程度为低中分化、Gleason评分≥6分前列腺癌根治术患者血清fPSA、CXCL4L1水平分别明显高于T分期为T1~2期、无淋巴结转移、分化程度为高分化、Gleason评分﹤6分的患者,差异均有统计学意义(P﹤0.01).随访结束,80例前列腺癌根治术患者,预后不良18例,预后良好62例.预后不良患者血清fPSA、CXCL4L1水平均明显高于预后良好患者,差异均有统计学意义(P﹤0.01).多因素Logistic回归分析结果显示,血清fPSA、CXCL4L1水平升高分别是前列腺癌根治术患者T3~4期、Gleason评分≥6分、低中分化、淋巴结转移及预后不良的独立危险因素(P﹤0.05).Pearson相关性分析结果显示,前列腺癌根治术患者血清fPSA水平与CXCL4L1水平呈正相关(r=0.314,P﹤0.01).结论 血清fPSA、CX-CL4L1水平与前列腺癌根治术患者的临床特征及预后有关,二者水平升高提示T分期高、淋巴结转移、分化程度低、Gleason评分高及预后不良.
Relationship between serum free prostate-specific antigen,C-X-C chemokine ligand 4L1 levels and clinical characteristic and prognosis of patients with prostate cancer undergoing radical prostatectomy
Objective To explore the relationship between serum free prostate-specific antigen(fPSA),C-X-C che-mokine ligand 4L1(CXCL4L1)levels and clinical characteristics and prognosis of patients with prostate cancer undergo-ing radical prostatectomy.Method The medical records of 80 patients with prostate cancer undergoing radical prostatec-tomy were collected,and the levels of fPSA,CXCL4L1 in different clinical characteristics of patients with prostate can-cer undergoing radical prostatectomy were compared.Follow up and record the prognosis,the serum levels of fPSA,CX-CL4L1 in different prognosis of patients with prostate cancer undergoing radical prostatectomy were compared.The clini-cal characteristics and prognostic influencing factors of patients with prostate cancer undergoing radical prostatectomy were analyzed by multivariate Logistic regression.Pearson correlation analysis was used for correlation analysis.Result The serum levels of fPSA,CXCL4L1 in patients with prostate cancer undergoing radical prostatectomy with T staging of T3-4,lymph node metastasis,low to moderate differentiation,and Gleason score≥6 points were significantly higher than those in patients with T staging of T1-2,no lymph node metastasis,high differentiation,and Gleason score<6 points,and the differences were statistically significant(P<0.01).At the end of the follow-up,among 80 patients with prostate cancer undergoing radical prostatectomy,18 cases had poor prognosis and 62 cases had good prognosis.The levels of serum fP-SA and CXCL4L1 in patients with poor prognosis were significantly higher than those in patients with good prognosis,and the differences were statistically significant(P<0.01).Multivariate Logistic regression analysis showed that the levels of serum fPSA and CXCL4L1 elevated were independent risk factors for T staging of T3-4,Gleason score≥6 points,low to moderate differentiation,lymph node metastasis,and poor prognosis in prostate cancer patients undergoing radical prosta-tectomy(P<0.05).Pearson correlation analysis results showed that the serum fPSA level of patients with prostate cancer undergoing radical prostatectomy was positively correlated with the CXCL4L1 level(r=0.314,P<0.01).Conclusion The levels of serum fPSA and CXCL4L1 are related to the clinical characteristics and prognosis of patients with prostate cancer undergoing radical prostatectomy.Elevated levels of both indexes indicate high T staging,lymph node metastasis,low differentiation,high Gleason score,and poor prognosis.

prostate cancerfree prostate-specific antigenC-X-C chemokine ligand 4L1clinical characteristicprognosis

邵长帅、任小强、王鸿渊

展开 >

河南科技大学临床医学院/河南科技大学第一附属医院泌尿外科,河南 洛阳 471003

前列腺癌 游离前列腺特异性抗原 CXC趋化因子配体4L1 临床特征 预后

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(23)